Dashboard
Manage Tickers

ADAP Adaptimmune Therapeutics PLC

Nasdaq adaptimmune.com


$ 0.20 $ -0.02 (-11.32 %)    

Thursday, 16-Oct-2025 16:00:32 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 600.16 $ -5.24 (-0.87 %)
DIA $ 459.58 $ -3.77 (-0.81 %)
SPY $ 660.77 $ -6.23 (-0.93 %)
TLT $ 91.31 $ 0.85 (0.94 %)
GLD $ 396.51 $ 5.21 (1.33 %)
$ 0.1841
$ 0.22
$ 0.20 x 400
$ 0.20 x 321
$ 0.19 - $ 0.24
$ 0.04 - $ 0.90
74,284,861
na
48.8M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-24-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-06-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-06-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-14-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-06-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-15-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-13-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-12-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION